IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
Europe - ELI:IBS - PTIBS0AM0008 - Common Stock
10.1 EUR
0 (0%)
Taking everything into account, IBS scores 4 out of 10 in our fundamental rating. IBS was compared to 53 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and the financial health of IBS get a neutral evaluation. Nothing too spectacular is happening here. IBS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year IBS was profitable.
IBS had a positive operating cash flow in the past year.
IBS had positive earnings in 4 of the past 5 years.
In the past 5 years IBS always reported a positive cash flow from operatings.
1.2 Ratios
IBS has a Return On Assets (1.51%) which is in line with its industry peers.
With a Return On Equity value of 3.42%, IBS perfoms like the industry average, outperforming 58.49% of the companies in the same industry.
The Return On Invested Capital of IBS (3.81%) is comparable to the rest of the industry.
IBS had an Average Return On Invested Capital over the past 3 years of 3.32%. This is significantly below the industry average of 11.50%.
The 3 year average ROIC (3.32%) for IBS is below the current ROIC(3.81%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 3.42% | ||
| ROIC | 3.81% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
1.3 Margins
IBS's Profit Margin of 2.07% is in line compared to the rest of the industry. IBS outperforms 47.17% of its industry peers.
In the last couple of years the Profit Margin of IBS has declined.
IBS's Operating Margin of 5.03% is in line compared to the rest of the industry. IBS outperforms 47.17% of its industry peers.
In the last couple of years the Operating Margin of IBS has declined.
IBS has a Gross Margin of 50.98%. This is comparable to the rest of the industry: IBS outperforms 54.72% of its industry peers.
In the last couple of years the Gross Margin of IBS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.03% | ||
| PM (TTM) | 2.07% | ||
| GM | 50.98% |
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBS is destroying value.
The number of shares outstanding for IBS has been reduced compared to 1 year ago.
Compared to 5 years ago, IBS has more shares outstanding
IBS has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.01 indicates that IBS is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.01, IBS is in the better half of the industry, outperforming 67.92% of the companies in the same industry.
The Debt to FCF ratio of IBS is 4.26, which is a neutral value as it means it would take IBS, 4.26 years of fcf income to pay off all of its debts.
IBS's Debt to FCF ratio of 4.26 is fine compared to the rest of the industry. IBS outperforms 71.70% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that IBS is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.71, IBS is doing good in the industry, outperforming 69.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 4.26 | ||
| Altman-Z | 2.01 |
ROIC/WACC0.61
WACC6.21%
2.3 Liquidity
IBS has a Current Ratio of 0.96. This is a bad value and indicates that IBS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Current ratio value of 0.96, IBS is doing good in the industry, outperforming 60.38% of the companies in the same industry.
A Quick Ratio of 0.87 indicates that IBS may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.87, IBS is doing good in the industry, outperforming 60.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
IBS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.51%.
IBS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
Looking at the last year, IBS shows a quite strong growth in Revenue. The Revenue has grown by 17.65% in the last year.
The Revenue has been decreasing by -0.46% on average over the past years.
EPS 1Y (TTM)-30.51%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%100%
Revenue 1Y (TTM)17.65%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%18.09%
3.2 Future
IBS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.15% yearly.
Based on estimates for the next years, IBS will show a small growth in Revenue. The Revenue will grow by 6.73% on average per year.
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.15%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.73%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 38.85 indicates a quite expensive valuation of IBS.
IBS's Price/Earnings ratio is in line with the industry average.
IBS's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.11.
Based on the Price/Forward Earnings ratio of 23.67, the valuation of IBS can be described as rather expensive.
IBS's Price/Forward Earnings is on the same level as the industry average.
IBS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.55, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.85 | ||
| Fwd PE | 23.67 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, IBS is valued a bit cheaper than 79.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.92 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
IBS's earnings are expected to grow with 20.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.36%
EPS Next 3Y20.34%
5. Dividend
5.1 Amount
IBS has a Yearly Dividend Yield of 7.01%, which is a nice return.
IBS's Dividend Yield is rather good when compared to the industry average which is at 3.22. IBS pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, IBS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.01% |
5.2 History
On average, the dividend of IBS grows each year by 48.65%, which is quite nice.
Dividend Growth(5Y)48.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IBS pays out 268.99% of its income as dividend. This is not a sustainable payout ratio.
IBS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP268.99%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
ELI:IBS (11/3/2025, 5:01:16 PM)
10.1
0 (0%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners21.88%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap419.25M
Revenue(TTM)511.65M
Net Income(TTM)10.61M
Analysts83.33
Price Target11.82 (17.03%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.01% |
Yearly Dividend0.49
Dividend Growth(5Y)48.65%
DP268.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.24%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)11.28%
Revenue beat(4)3
Avg Revenue beat(4)8.29%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)12.41%
Revenue beat(8)7
Avg Revenue beat(8)6.42%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-72.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-36.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)18.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.85 | ||
| Fwd PE | 23.67 | ||
| P/S | 0.82 | ||
| P/FCF | 5.92 | ||
| P/OCF | 3.6 | ||
| P/B | 1.35 | ||
| P/tB | 1.98 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.26
EY2.57%
EPS(NY)0.43
Fwd EY4.23%
FCF(TTM)1.71
FCFY16.9%
OCF(TTM)2.81
OCFY27.81%
SpS12.33
BVpS7.47
TBVpS5.09
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 3.42% | ||
| ROCE | 4.85% | ||
| ROIC | 3.81% | ||
| ROICexc | 4.93% | ||
| ROICexgc | 6.48% | ||
| OM | 5.03% | ||
| PM (TTM) | 2.07% | ||
| GM | 50.98% | ||
| FCFM | 13.85% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
ROICexc(3y)5.24%
ROICexc(5y)N/A
ROICexgc(3y)7.05%
ROICexgc(5y)N/A
ROCE(3y)4.21%
ROCE(5y)N/A
ROICexgc growth 3Y-24.94%
ROICexgc growth 5Y-3.32%
ROICexc growth 3Y-22.88%
ROICexc growth 5Y-3.24%
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
F-Score6
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 4.26 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 8.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 667.98% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 2.01 |
F-Score6
WACC6.21%
ROIC/WACC0.61
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.76%
Cap/Sales(5y)11.65%
Profit Quality(3y)200.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.51%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%100%
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.15%
Revenue 1Y (TTM)17.65%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%18.09%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.73%
EBIT growth 1Y19.24%
EBIT growth 3Y-20.54%
EBIT growth 5Y-7.19%
EBIT Next Year434.69%
EBIT Next 3Y84.16%
EBIT Next 5Y57.26%
FCF growth 1Y26.38%
FCF growth 3Y-0.14%
FCF growth 5Y-9.32%
OCF growth 1Y23.94%
OCF growth 3Y1.82%
OCF growth 5Y-6.35%
IBERSOL SGPS SA / IBS.LS FAQ
What is the ChartMill fundamental rating of IBERSOL SGPS SA (IBS.LS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to IBS.LS.
What is the valuation status for IBS stock?
ChartMill assigns a valuation rating of 2 / 10 to IBERSOL SGPS SA (IBS.LS). This can be considered as Overvalued.
Can you provide the profitability details for IBERSOL SGPS SA?
IBERSOL SGPS SA (IBS.LS) has a profitability rating of 4 / 10.
Can you provide the financial health for IBS stock?
The financial health rating of IBERSOL SGPS SA (IBS.LS) is 4 / 10.
What is the earnings growth outlook for IBERSOL SGPS SA?
The Earnings per Share (EPS) of IBERSOL SGPS SA (IBS.LS) is expected to decline by -16.54% in the next year.